2025 Oncology Updates for Advanced Practice Providers

Join us for the 2025 Oncology Updates for APPs, a one and a half day virtual conference focusing on new strategies for cancer treatment including treatments for pancreatic cancer, Tumor-infiltrating lymphocyte (TIL) therapy for melanoma, diagnosis and management of adult hemophagocytic lymphohistiocytosis, management of complications and hypersensitivities from post hyperthermic intraperitoneal chemotherapy, discussion of radiologic readings of lung disease, pneumonitis evaluation and treatment, cardio-oncology updates, menopause management in hormone sensitive cancers, and more. By the end of this course, learners will be able to identify latest research and updated practice guidelines of the oncology population that they can apply to their practice.

This is a virtual class via Zoom.

**This will be a live webinar and you will need a computer with internet access to view the meeting. Instructions on how to login will be emailed upon registration.

1. Identify latest research and updated practice guidelines of the oncology population that they can apply to their practice.
2. Indicate when unintended biases may contribute to decisions made when caring for a patient, and how to mitigate those biases.

1. Identify latest research and updated practice guidelines of the oncology population that they can apply to their practice.
2. Indicate when unintended biases may contribute to decisions made when caring for a patient, and how to mitigate those biases.

1. Stanford Health Care is provider approved by the California Board of Registered Nursing (BRN).  Provider Number CEP12165.
2. Stanford Health Care Center for Education and Professional Development is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
*Neither SHC nor ANCC endorse any commercial products

3. This activity has been reviewed by the American Academy of Physician Associates Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 10.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. Approval is valid from 3/13/2025 to 3/14/2025. AAPA reference number: CME-2013008.

Mitigation of Relevant Financial Relationships

Stanford Health Care (SHC) adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant financial relationships have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Arati Jairam-thodla, NP
Stanford Health Care

Content Expert

Nothing to disclose

Ryan Batchelder, Physician Assistant
Stanford Health Care

Faculty

Nothing to disclose

Allison Betof Warner, MD
Stanford University

Faculty

Consulting Fee-Adaptimmune|Grant or research support-Replimune|Grant or research support-Immunocore|Membership on Advisory Committees or Review Panels, Board Membership, etc.-cTRL Therapeutics|Consulting Fee-Bristol-Myers Squibb (Relationship has ended)|Consulting Fee-Genmab (Relationship has ended)|Consulting Fee-Immatics (Relationship has ended)|Consulting Fee-IO Biotech (Relationship has ended)|Consulting Fee-Iovance Biotherapeutics (Relationship has ended)|Consulting Fee-Novartis AG (Relationship has ended)|Consulting Fee-Merck and Company, Inc.|Consulting Fee-Pfizer, Inc. (Relationship has ended)|Consulting Fee-Replimune (Relationship has ended)|Grant or research support-Bristol-Myers Squibb|Grant or research support-Iovance Biotherapeutics (Relationship has ended)|Grant or research support-Lyell Immunopharma|Grant or research support-Obsidian Therapeutics

Jonathan Cheong, MSPA
Stanford Health Care

Faculty

Nothing to disclose

Daniel Delitto, MD
Stanford University

Faculty

Nothing to disclose

Aisha Furqan, MS, Genetic Counselor
Stanford Health Care

Faculty

Nothing to disclose

Henry Guo, MD
Stanford

Faculty

Paid consultant-Exact Sciences

Melanie Hayden Gephart, MD
Stanford University

Faculty

Grant or research support-Quadriga|Stocks or stock options, excluding diversified mutual funds – in a publicly held company-SmartLens|Advisor-SensoBrain|Advisor-Telix

Byrne Lee, MD
Stanford University

Faculty

Nothing to disclose

Beth A Martin-Kool, MD, Clinical Associate Professor
Stanford

Faculty

Nothing to disclose

SHILPA NARAYAN, MS in Human Genetics and Genetic Counseling , LCGC
Stanford Health Care

Faculty

Nothing to disclose

Kathryne Sanserino, MD
Stanford Health Care

Faculty

Nothing to disclose

Deepa Shah, BSN , PA-C
Stanford Health Care

Faculty

Nothing to disclose

Sonya Feng, MSN
Stanford Health Care

Nurse Planner (CEPD Staff Only)

Nothing to disclose

Jason Kao, MHS
Stanford Health Care

Other Planning Committee Member

Nothing to disclose

Chandley Silin, MSN
Stanford Health Care

Other Planning Committee Member

Nothing to disclose

Jenny Veliz-Urzua, MSN
Stanford Health Care

Other Planning Committee Member

Other: Investor-Volta